These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6728255)

  • 21. Effect of bezafibrate on lipids, lipoproteins, apolipoproteins and platelet aggregation in hypertriglyceridemic patients.
    Waysbort J; Schwartz S; Brunner D
    Arzneimittelforschung; 1994 Nov; 44(11):1217-22. PubMed ID: 7893284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms underlying the morning increase in platelet aggregation: a flow cytometry study.
    Andrews NP; Gralnick HR; Merryman P; Vail M; Quyyumi AA
    J Am Coll Cardiol; 1996 Dec; 28(7):1789-95. PubMed ID: 8962568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of PF3 availability in whole blood from volunteers and beta-thalassemia/HbE patients: a promising method for prediction of thrombotic tendency.
    Opartkiattikul N; Funahara Y; Hijikata-Okunomiya A; Yamaguchi N; Fucharoen S; Talalak P
    Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():52-9. PubMed ID: 1298994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of platelet fibronectin, ADP-induced platelet aggregation and serum total nitric oxide (NOx) levels in angiographically determined coronary artery disease.
    Ekmekçi H; Işler I; Sönmez H; Gürel C; Ciftçi O; Ulutin T; Kökoğlu E; Domaniç N; Dirican A
    Thromb Res; 2006; 117(3):249-54. PubMed ID: 16378831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine diphosphate-induced platelet aggregation correlates with platelet activation identified with the use of flow cytometry.
    García M; Schneider DJ
    Pathophysiol Haemost Thromb; 2008; 36(2):75-9. PubMed ID: 19127086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in several blood coagulation parameters in the nephrotic syndrome].
    Gasparotto ML; Bertoli M; Bertaglia E; Vertolli U; Varchetta V; Favaro P; Rebeschini M; Di Lavoro D; Romagnoli GF
    Minerva Nefrol; 1981; 28(1):15-9. PubMed ID: 6793942
    [No Abstract]   [Full Text] [Related]  

  • 27. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An unusual platelet function defect: report of 19 cases.
    Saxena R; Gupta M; Gupta S; Choudhry VP
    Indian J Pathol Microbiol; 2003 Oct; 46(4):576-8. PubMed ID: 15025347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sex difference on platelet aggregation using an optical method in healthy subjects.
    Beyan C; Kaptan K; Ifran A; Savaşçi S; Oztürk Y; Okmen B
    Clin Lab Haematol; 2006 Feb; 28(1):14-6. PubMed ID: 16430454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effect of ethanol on ADP and collagen-induced platelet aggregation.
    Bengmark S; Elmér O; Göransson G; Zoucas E
    Thromb Haemost; 1981 Dec; 46(4):673-5. PubMed ID: 7330816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Potentiating effect of some fatty acids on platelet aggregation induced with ADP, collagen and 1-epinephrine].
    Musso R; Russo M; Raimondo V
    Boll Soc Ital Biol Sper; 1980 Mar; 56(6):569-75. PubMed ID: 7378191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment.
    Arends JP; Krediet RT; Boeschoten EW; van der Lelie J; Veenhof CH; von dem Borne AE
    Proc Eur Dial Transplant Assoc; 1981; 18():280-5. PubMed ID: 7329972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
    Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B
    Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood hyperviscosity in psoriasis.
    Wolf R; Machtey I; Feuerman EJ; Creter D
    Acta Derm Venereol; 1981; 61(2):153-4. PubMed ID: 6165194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
    Zuk E
    Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B; Sabovic M; Zupan IP; Ponikvar JB
    Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
    Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective platelet aggregation in myelodysplastic syndromes.
    Girtovitis FI; Ntaios G; Papadopoulos A; Ioannidis G; Makris PE
    Acta Haematol; 2007; 118(2):117-22. PubMed ID: 17726306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leptin does not play a major role in platelet aggregation in obesity and leptin deficiency.
    Ozata M; Avcu F; Durmus O; Yilmaz I; Ozdemir IC; Yalcin A
    Obes Res; 2001 Oct; 9(10):627-30. PubMed ID: 11595779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.